Study of Individualized Amonafide to Treat Prostate Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mario Eisenberger, MD
Johns Hopkins University Hospital
Principal Investigator - Michel Drouin, MD
Xanthus Life Sciences-Medical Monitor
Study Chair - Monique Champagne, BPharm, MSc
Xanthus Pharmaceuticals, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Usc Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Cancer Center at John Hopkins
Baltimore, Maryland, United States
- Barnard Cancer Center
St Louis, Missouri, United States
- Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Herbert Irving Cancer Center
New York, New York, United States
- the Cleveland Clinic
Cleveland, Ohio, United States
- Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2004
- Primary completion
- 31 Dec 2005
- Completion
- 31 Dec 2005
- Last update posted
- 23 Apr 2008
- Registered enrollment
- 40
- Registry id
- NCT00087854
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.